Uniphar (LON:UPR) Hits New 52-Week Low – Time to Sell?

Uniphar plc (LON:UPR) hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 166 ($2.09) and last traded at GBX 166.65 ($2.10), with a volume of 19668 shares trading hands. The stock had previously closed at GBX 171.50 ($2.16).

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 310 ($3.90) target price on shares of Uniphar in a research note on Wednesday, September 4th.

Uniphar Stock Up 3.6 %

The company has a debt-to-equity ratio of 119.43, a current ratio of 0.90 and a quick ratio of 0.60. The firm has a 50 day simple moving average of GBX 203.57 and a 200-day simple moving average of GBX 212.98. The stock has a market capitalization of £475.05 million, a price-to-earnings ratio of 1,211.71 and a beta of 0.75.

Uniphar Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, October 4th. Stockholders of record on Thursday, September 12th were paid a €0.01 ($0.01) dividend. The ex-dividend date was Thursday, September 12th. This represents a dividend yield of 0.25%. Uniphar’s dividend payout ratio (DPR) is presently 1,428.57%.

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.